Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Terbinafine EP Impurity E

● In Stock

Catalogue No.:	VL930001
CAS No.:	N/A
Mol. Formula:	C36H42Cl2N2
Mol. Weight:	573.64 g/mol

Request a quote

Add to RFQ list

Additional information on Terbinafine EP Impurity E

Parent drug

Terbinafine

IUPAC Name

(2E, 4E)-4-(4, 4-Dimethyl-2-pentyn-1-ylidene)-N1, N5-dimethyl-N1, N5-bis(1-naphthalenylmethyl)-2-pentene-1, 5-diamine Dihydrochloride Salt

Pharmacopoeial Synonyms

Terbinafine BP Impurity E

Other Synonyms

Terbinafine Dimer Impurity

Smiles

CN(CC1=C2C=CC=CC2=CC=C1)CC(/C=C/CN(C)CC3=C4C=CC=CC4=CC=C3)=C/C#CC(C)(C)C.[H]Cl.[H]Cl

InChI

InChI=1S/C36H40N2.2ClH/c1-36(2,3)24-12-14-29(26-38(5)28-33-21-11-19-31-17-7-9-23-35(31)33)15-13-25-37(4)27-32-20-10-18-30-16-6-8-22-34(30)32;;/h6-11,13-23H,25-28H2,1-5H3;2*1H/b15-13+,29-14+;;

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Description

Terbinafine EP Impurity E also known in pharmacopoeias as Terbinafine BP Impurity E is a thoroughly characterized reference standard. It meets strict regulatory standards including those set by USP EMA JP and BP. This product is crucial for use in Abbreviated New Drug Applications (ANDA) New Drug Applications (NDA) and the commercial production of Terbinafine. Additionally it comes with a detailed Structure Elucidation Report (SER) ensuring its precision and dependability for a variety of analytical uses. Terbinafine EP Impurity E is an impurity of Terbinafine. It is also chemically known as Terbinafine Dimer Impurity. Terbinafine inhibits ergosterol synthesis by inhibiting squalenceepoxidase, which is antifungal agent indicated for both oral and topical treatment of mycosessince.